World Cancer Biological Therapy Market to See 4.7% CAGR by 2023, Forecasts MRFR in Its In-demand Report Available at MarketPublishers.com
29 Aug 2017 • by Natalie Aster
LONDON – Worldwide, the cancer biological therapy market is projected to see a 4.7% CAGR, amounting to USD 82,276.8 million by 2023. The market growth is being driven by the increasing survival rates for cancer, rising demand for advanced treatment modalities, fewer side effects as against traditional therapies, changing lifestyles, as well as expanding smoking population in the Middle East & Africa region. However, high cost of cancer biological therapy could act as the major challenge to the market growth.
Based on type, the colony stimulating factor segment is poised to record the fastest CAGR of 5.2% over the projected period. With respect to end-use sector, hospitals and clinics capture the lion’s share of the market posting 47.8% of the overall cancer biological therapy market in 2016.
Region-wise, North America is a global leader. The regional market value stood at over USD 19.481 billion in 2016 and is projected to be around USD 29.517 billion by 2023, posting 5.10% CAGR.
Merck, Novartis, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Celgene, Pfizer, ELI Lilly and Company, and EnGeneIC, are the leading players in the market.
In-demand report “Global Cancer Biological Therapy Analysis & Forecast 2016 To 2023” created by MRFR is aimed at providing an all-round assessment of the market on a global level.
The research offers a detailed assessment of the market structure. It segments the market based on phase, type, end-use sector, and region-wise; providing historical and projected revenue figures for the market segments and sub-segments across the leading nations. The report gives true insights into the key factors shaping and impacting the market growth; strategically profiles top players in the industry, and comprehensively examines their market share, key competencies, as well as limelights the overall competitive scenario of the market. The study discusses the economical factors that have a bearing on the worldwide cancer biological therapy sector. It also includes a granular analysis of the supply and value chains of the overall market.
Go to Market Research Future page to find a comprehensive collection of the publisher’s research studies.